Evidence map›Paper›PMID 41450347›Full record

ArticleCureus2025

Prognostication: A Young Patient With AA Amyloidosis.

Jennifer Inglis-Taylor, Laurie Powell

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jennifer Inglis-TaylorPalliative Care, Great Western Hospital, Swindon, GBR.
Laurie PowellPalliative Care, Great Western Hospital, Swindon, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Young patients and patients with multiple comorbidities often present a challenge of prognostic uncertainty. We present a case of a patient with end-stage renal failure secondary to AA amyloidosis from ongoing IV heroin use. This case presented difficulties with ethics, analgesia, prognostication, and, therefore, advanced care planning and communication challenges. These were overcome with multi-disciplinary input and careful communication with the patient and family members. The learning points include: the need for early and personalised advanced care planning, better provision of end-of-life care for patients with chaotic lifestyles and appropriate use of the ethics committee.

Indexed as

aa amyloidosisadvanced care planningend-of-life and hospice careopioid prescribingwritten and verbal communication

Identifiers

PMID41450347
PMCPMC12728888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.